IP Verse

Secerna competitive analysis

Loading summary...

Explore patent oppositions filed by Secerna against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3506931	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Apr 30, 2025
EP3889181	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jan 23, 2025
EP3110848	Methods For Treating Skin Infection By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Nov 13, 2024
EP3515465	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	REGENERON PHARMACEUTICALS	Nov 6, 2024
EP3973987	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Oct 9, 2024
EP4011915	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 10, 2024
EP3470432	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 5, 2022
EP2872171	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Oct 5, 2021
EP3338794	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Nov 26, 2020
EP3312196	Antibodies Against Cd38 For Treatment Of Multiple Myeloma	GENMAB	Apr 16, 2020

Explore the latest publications and patents granted to Secerna, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Secerna, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Secerna with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SECERNA	11	-	-	-
GENMAB	6	8	-	-
REGENERON PHARMACEUTICALS	38	94	9	31
SANOFI BIOTECHNOLOGY	-	51	-	-